Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity

Jul 2020  Jun 2020  May 2020  Apr 2020  Mar 2020  Feb 2020  Jan 2020  Dec 2019  Nov 2019  Oct 2019  Sep 2019  Aug 2019  Jul 2019  Jun 2019  May 2019  Apr 2019  Mar 2019  Feb 2019  Jan 2019  Dec 2018  Nov 2018  Oct 2018  Sep 2018  Aug 2018  Jul 2018  Jun 2018  May 2018  Apr 2018  Mar 2018  Feb 2018  Jan 2018  Dec 2017  Nov 2017  Oct 2017  Sep 2017  Aug 2017  Jul 2017  Jun 2017  May 2017  Apr 2017  Mar 2017  Feb 2017  Jan 2017  Dec 2016  Nov 2016  Oct 2016  Sep 2016  Aug 2016  Jul 2016  Jun 2016  May 2016  Apr 2016  Mar 2016  Feb 2016  Jan 2016  Dec 2015  Nov 2015  Oct 2015  Sep 2015  Aug 2015  Jul 2015  Jun 2015  

Notifications
The following Independence Blue Cross commercial policies have been posted prior to their effective date.
08.01.30, Daptomycin (Cubicin®)
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/01/2016
Type of policy change: This is a new policy.

07.13.06h, Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/01/2016
Type of policy change: Medical Coding

11.03.12m, Colorectal Cancer Screening
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/01/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

05.00.79, Insulin Pumps
Notification: 12/01/2016 (revised 12/08/2016) | Effective: 01/01/2017 | Posted: 12/01/2016
Type of policy change: This is a new policy.

05.00.24n, Interstitial Continuous Glucose Monitoring Systems (CGMSs)
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/01/2016
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update

08.01.35, Asparaginase Erwinia Chrysanthemi (Erwinaze®)
Notification: 12/02/2016 | Effective: 01/01/2017 | Posted: 12/02/2016
Type of policy change: This is a new policy.

08.01.04o, Immunizations
Notification: 12/02/2016 (revised 12/13/2016) | Effective: 01/01/2017 | Posted: 12/02/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

06.02.52b, eviCore Lab Management Program
Notification: 12/02/2016 | Effective: 01/02/2017 | Posted: 12/02/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.01.33, Gonadotropin Releasing Hormone Agonist (Eligard®, Lupron Depot®)
Notification: 12/14/2016 | Effective: 03/14/2017 | Posted: 12/14/2016
Type of policy change: This is a new policy.

00.01.47c, Inpatient Hospital Readmission
Notification: 12/15/2016 | Effective: 01/15/2017 | Posted: 12/15/2016
Type of policy change: Coverage and/or Reimbursement Position; General Description, Guidelines, or Informational Update

08.00.94i, Denosumab (Prolia ®, Xgeva®)
Notification: 12/15/2016 | Effective: 03/14/2017 | Posted: 12/15/2016
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

08.00.74j, Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists (eg, ranibizumab [Lucentis®], pegaptanib sodium [Macugen®], aflibercept [Eylea®])
Notification: 12/28/2016; revised 02/16/2017 | Effective: 03/28/2017 | Posted: 12/28/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update


New Policies
The following commercial policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross
08.01.30, Daptomycin (Cubicin®)
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: This is a new policy.

05.00.79, Insulin Pumps
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: This is a new policy.

08.01.35, Asparaginase Erwinia Chrysanthemi (Erwinaze®)
Notification: 12/02/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: This is a new policy.

08.01.32, Pegfilgrastim (Neulasta®)
Notification: 09/30/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: This is a new policy.

08.01.31, Fulvestrant (Faslodex®)
Notification: 09/30/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: This is a new policy.


Updated Policies
The following commercial policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
07.00.03n, Full-Body Monoplace or Multiplace Chamber Hyperbaric Oxygen Therapy
Notification: 09/02/2016 | Effective: 12/01/2016 | Posted: 12/01/2016
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

07.10.06d, Assisted Reproductive Technology for Infertility and Oocyte Cryopreservation
Notification: 09/02/2016 | Effective: 12/01/2016 | Posted: 12/01/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

09.00.10u, Brachytherapy (Independence Administrators)
Effective: 12/05/2016 | Posted: 12/05/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

11.08.10g, Excision of Redundant Skin
Effective: 12/05/2016 | Posted: 12/05/2016
Type of policy change: Medical Coding

08.00.78t, Self-Administered Drugs
Notification: 11/11/2016 | Effective: 12/12/2016 | Posted: 12/12/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding

07.07.02i, Ultraviolet Light Therapy for the Treatment of Dermatological Conditions
Effective: 12/14/2016 | Posted: 12/14/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

07.05.02n, Wireless Capsule Endoscopy (WCE) as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus, and Colon
Effective: 12/16/2016 | Posted: 12/16/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding

08.00.08h, Radioimmunotherapy with Ibritumomab Tiuxetan (Zevalin®) (Independence Administrators)
Effective: 12/16/2016 | Posted: 12/16/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding

11.02.25e, Transcatheter Cardiac Valve Procedures
Notification: 11/23/2016 | Effective: 12/23/2016 | Posted: 12/23/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.00.13r, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
Effective: 12/28/2016 | Posted: 12/28/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.00.76g, Oxaliplatin (Eloxatin®)
Effective: 12/28/2016 | Posted: 12/28/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.00.62g, Abatacept (Orencia®) for Injection for Intravenous Use
Effective: 12/28/2016 | Posted: 12/28/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.00.85f, Tocilizumab (Actemra®) for Intravenous Infusion
Effective: 12/28/2016 | Posted: 12/28/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.01.15b, Golimumab (Simponi Aria®) Intravenous (IV) Injection
Effective: 12/28/2016 | Posted: 12/28/2016

06.02.52b, eviCore Lab Management Program
Notification: 12/02/2016 | Effective: 01/02/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

00.06.02s, Preventive Care Services
Notification: 11/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

08.01.04o, Immunizations
Notification: 12/02/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

07.13.06h, Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding

11.14.24a, Manipulation Under Anesthesia
Notification: 09/30/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

11.09.02c, Treatment of Gender Dysphoria
Notification: 11/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

11.00.13f, Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Notification: 09/30/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding

11.14.22d, Spinal Decompression with Interspinous and Interlaminar Devices
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update

09.00.56c, Radiation Therapy Services
Notification: 09/30/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding

05.00.24n, Interstitial Continuous Glucose Monitoring Systems (CGMSs)
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update

11.03.12m, Colorectal Cancer Screening
Notification: 12/01/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

07.13.07i, Corneal Pachymetry Using Ultrasound
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding

11.05.01d, Refractive Keratoplasty
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

09.00.32q, Diagnostic and Therapeutic Radiopharmaceutical Agents
Notification: 10/03/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position

12.01.01ai, Experimental/Investigational Services
Notification: 09/30/2016 | Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Coding

11.03.11n, Procedures for the Treatment of Gastroesophageal Reflux Disease (GERD)
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

08.01.27b, Talimogene laherparepvec (Imlygic™)
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Medical Necessity Criteria; Medical Coding

00.10.41a, Telemedicine for Primary Care Services
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding; General Description, Guidelines, or Informational Update

00.01.59b, Care Management and Care Planning Services
Effective: 01/01/2017 | Posted: 12/30/2016
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding


Reissue Policies
The following commercial policies have been reviewed, and no substantive changes were made.
07.00.01g, Biofeedback Therapy
Reissue Effective: 12/02/2016 | Reissue Posted: 12/02/2016

08.00.67i, Cetuximab (Erbitux®)
Reissue Effective: 12/02/2016 | Reissue Posted: 12/02/2016

08.00.75k, Erythropoiesis-Stimulating Agents (ESAs)
Reissue Effective: 12/02/2016 | Reissue Posted: 12/02/2016

08.00.88c, Ofatumumab (Arzerra™)
Reissue Effective: 12/05/2016 | Reissue Posted: 12/05/2016

08.00.95d, Personalized Vaccines (e.g. Provenge®)
Reissue Effective: 12/05/2016 | Reissue Posted: 12/05/2016

08.00.98c, Eribulin Mesylate (Halaven®)
Reissue Effective: 12/05/2016 | Reissue Posted: 12/05/2016

11.02.10k, Endovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aortic-Iliac Aneurysms, and Infrarenal Aortic Aneurysms
Reissue Effective: 12/05/2016 | Reissue Posted: 12/05/2016

11.05.02g, Blepharoplasty, Repair of Blepharoptosis, Repair of Brow Ptosis, and Canthoplasty/Canthopexy
Reissue Effective: 12/05/2016 | Reissue Posted: 12/05/2016

11.08.06g, Abdominoplasty and/or Panniculectomy
Reissue Effective: 12/05/2016 | Reissue Posted: 12/05/2016

05.00.74a, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Reissue Effective: 12/09/2016 | Reissue Posted: 12/09/2016

11.08.04h, Selective Photothermolysis Using Pulsed-Dye Lasers (PDL)
Reissue Effective: 12/09/2016 | Reissue Posted: 12/09/2016

11.08.03i, Lipectomy and Liposuction
Reissue Effective: 12/09/2016 | Reissue Posted: 12/09/2016

11.00.02f, Treatment of Medical and Surgical Complications
Reissue Effective: 12/09/2016 | Reissue Posted: 12/09/2016

11.08.13f, Rhytidectomy and/or Cervicoplasty With or Without Liposuction and/or Platysmaplasty
Reissue Effective: 12/09/2016 | Reissue Posted: 12/09/2016

11.08.20o, Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds
Reissue Effective: 12/12/2016 | Reissue Posted: 12/12/2016

05.00.62g, Injectable Dermal Fillers
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

01.00.03b, Organ and Tissue Recovery from a Cadaveric Donor and Associated Services
Reissue Effective: 12/09/2016 | Reissue Posted: 12/14/2016

11.03.01d, Repair of Cleft Lip, Cleft Nose, and/or Cleft Palate
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

11.00.09e, Solid Organ Transplants
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

11.08.15t, Reconstructive Breast Surgery
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

11.08.05g, Application and Removal of Tattoos
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

11.14.01f, Mentoplasty or Genioplasty
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

12.04.02f, Nonemergency Ambulance Transport Services
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

11.03.02p, Bariatric Surgery
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

11.08.25l, Scar Revision
Reissue Effective: 12/14/2016 | Reissue Posted: 12/14/2016

06.03.04k, Apheresis Therapy
Reissue Effective: 12/21/2016 | Reissue Posted: 12/21/2016

11.08.23h, Mohs' Micrographic Surgery
Reissue Effective: 12/21/2016 | Reissue Posted: 12/21/2016

05.00.09h, Electrical Bone Growth Stimulation and Low-Intensity Ultrasound Accelerated Fracture Healing System
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

11.14.14e, Percutaneous Intradiscal Annuloplasty (IDET/PIRFT)
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

06.02.26b, In Vitro Allergy Testing
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

07.07.09e, Stem-Cell Therapy for Orthopedic Applications and Autologous Platelet-Derived Growth Factors (PDGFs)/Platelet-Rich Plasmas (PRPs) for Acute or Chronic Wound Healing and Other Miscellaneous Conditions
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

07.00.05f, In Vivo Allergy Sensitivity Testing
Reissue Effective: 12/22/2016 | Reissue Posted: 12/22/2016

07.08.03c, Medical and Surgical Treatment of Temporomandibular Joint Disorder
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

11.14.27, Spinal Fusion
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

11.16.01g, Septoplasty, Rhinoplasty, and Septorhinoplasty
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

11.14.11f, Arthroscopic Electrothermal Joint Repair
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

08.01.21a, Blinatumomab (Blincyto™)
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

10.02.02g, Chiropractic Spinal and Extraspinal Manipulation Therapy
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

07.11.02e, Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders
Reissue Effective: 12/21/2016 | Reissue Posted: 12/22/2016

08.01.03c, Belatacept (Nulojix®)
Reissue Effective: 12/21/2016 | Reissue Posted: 12/23/2016


Coding Update
The following commercial policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
11.14.29a, Spinal Discectomy
Effective: 01/01/2017 | Posted: 12/30/2016

11.14.07q, Intra-Articular Injection of Hyaluronan for the Treatment of Osteoarthritis
Effective: 01/01/2017 | Posted: 12/30/2016

11.15.15f, Percutaneous Discectomy
Effective: 01/01/2017 | Posted: 12/30/2016

11.15.22d, Percutaneous Image-Guided Lumbar Decompression (PILD) for Spinal Stenosis
Effective: 01/01/2017 | Posted: 12/30/2016

11.15.23e, Epidural, Paravertebral Facet, and Sacroiliac Joint Injections for Spinal Pain Management
Effective: 01/01/2017 | Posted: 12/30/2016

11.14.13g, Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions
Effective: 01/01/2017 | Posted: 12/30/2016

08.01.29b, Daratumumab (Darzalex™)
Effective: 01/01/2017 | Posted: 12/30/2016

08.00.92r, Coagulation Factors
Effective: 01/01/2017 | Posted: 12/30/2016

06.03.04l, Apheresis Therapy
Effective: 01/01/2017 | Posted: 12/30/2016

08.00.18l, Nutritional Formulas, Enteral Nutrition, Medical Foods, and Low-Protein Modified Food Products
Effective: 01/01/2017 | Posted: 12/30/2016

11.02.01m, Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence
Effective: 01/01/2017 | Posted: 12/30/2016

03.00.20g, Modifiers 26 (Professional Component) and TC (Technical Component)
Effective: 01/01/2017 | Posted: 12/30/2016

08.00.78u, Self-Administered Drugs
Effective: 01/01/2017 | Posted: 12/30/2016

08.01.23c, Interleukin-5 Antagonist for Severe Eosinophilic Asthma (e.g., Nucala®, Cinqair®)
Effective: 01/01/2017 | Posted: 12/30/2016

07.03.14l, Intraoperative Neurophysiological Monitoring (INM)
Effective: 01/01/2017 | Posted: 12/30/2016

08.00.34h, Infliximab (Remicade®)
Effective: 01/01/2017 | Posted: 12/30/2016

11.02.26a, Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
Effective: 01/01/2017 | Posted: 12/30/2016

10.03.01g , Physical Medicine, Rehabilitation, and Habilitation Services
Effective: 01/01/2017 | Posted: 12/30/2016

11.08.20p, Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds
Effective: 01/01/2017 | Posted: 12/30/2016

07.03.07p, Evaluation and Management of Autism Spectrum Disorders (ASD)
Effective: 01/01/2017 | Posted: 12/30/2016

09.00.10v, Brachytherapy (Independence Administrators)
Effective: 01/01/2017 | Posted: 12/30/2016

08.00.57j, Complex Regional Pain Syndrome (CRPS) Parenteral Treatments
Effective: 01/01/2017 | Posted: 12/30/2016

08.01.28b, Sebelipase alfa (Kanuma®)
Effective: 01/01/2017 | Posted: 12/30/2016

00.10.17g, Modifier 66: Surgical Team
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.47m, Knee Braces
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.67m, Wheelchair Options and Accessories
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.39n, Ankle-Foot/Knee-Ankle-Foot Orthoses
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.43f, Seat Lift Mechanisms
Effective: 01/01/2017 | Posted: 12/30/2016

00.10.18i, Modifiers for Assistant-at-Surgery Services: 80, 81, 82, and AS
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.44i, Repair and Replacement of Durable Medical Equipment (DME)
Effective: 01/01/2017 | Posted: 12/30/2016

00.10.11j, Modifier 62: Two Surgeons
Effective: 01/01/2017 | Posted: 12/30/2016

11.15.03i, Insertion of Implantable Infusion Pumps
Effective: 01/01/2017 | Posted: 12/30/2016

03.00.05h, Modifier 50: Bilateral Procedure
Effective: 01/01/2017 | Posted: 12/30/2016

07.12.01e, Pelvic Floor Stimulation as a Treatment of Incontinence
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.21r, Durable Medical Equipment (DME)
Effective: 01/01/2017 | Posted: 12/30/2016

06.02.47b, Noninvasive Prenatal Screening for Fetal Aneuploidies Using Cell-Free Fetal DNA
Effective: 01/01/2017 | Posted: 12/30/2016

11.05.16e, Aqueous Shunts, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
Effective: 01/01/2017 | Posted: 12/30/2016

06.02.44b, Presumptive and Definitive Drug Testing
Effective: 01/01/2017 | Posted: 12/30/2016

11.14.27a, Spinal Fusion
Effective: 01/01/2017 | Posted: 12/30/2016

05.00.05j, Equipment, Supplies, and Pharmaceuticals for the Treatment of Diabetes
Effective: 01/01/2017 | Posted: 12/30/2016

06.02.31f, Genetic Testing for Congenital Long QT Syndrome
Effective: 01/01/2017 | Posted: 12/30/2016

06.02.35k, Genetic Testing
Effective: 01/01/2017 | Posted: 12/30/2016

00.01.25ai, PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services
Effective: 01/01/2017 | Posted: 12/30/2016


Archived Policies
Independence Blue Cross has determined that it is no longer necessary for the following commercial policy to remain active.
08.00.81e, Bendamustine Hydrochloride (Treanda®)
Notification: 12/13/2016 | Archive Effective: 01/14/2017 | Posted: 12/13/2016


Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.